
Capricor Therapeutics Inc
NASDAQ:CAPR

Intrinsic Value
The intrinsic value of one
CAPR
stock under the Base Case scenario is
40.27
USD.
Compared to the current market price of 12.73 USD,
Capricor Therapeutics Inc
is
Undervalued by 68%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Capricor Therapeutics Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Capricor Therapeutics Inc
Balance Sheet Decomposition
Capricor Therapeutics Inc
Current Assets | 146.3m |
Cash & Short-Term Investments | 144.8m |
Receivables | 59.8k |
Other Current Assets | 1.4m |
Non-Current Assets | 7.5m |
PP&E | 7.3m |
Other Non-Current Assets | 253.4k |
Free Cash Flow Analysis
Capricor Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Capricor Therapeutics Inc
Revenue
|
17.4m
USD
|
Operating Expenses
|
-74.6m
USD
|
Operating Income
|
-57.3m
USD
|
Other Expenses
|
2.2m
USD
|
Net Income
|
-55.1m
USD
|
CAPR Profitability Score
Profitability Due Diligence
Capricor Therapeutics Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Score
Capricor Therapeutics Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
CAPR Solvency Score
Solvency Due Diligence
Capricor Therapeutics Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Score
Capricor Therapeutics Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CAPR Price Targets Summary
Capricor Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
CAPR
is 42.97 USD
with a low forecast of 25.25 USD and a high forecast of 80.85 USD.
Dividends
Current shareholder yield for CAPR is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CAPR
stock under the Base Case scenario is
40.27
USD.
Compared to the current market price of 12.73 USD,
Capricor Therapeutics Inc
is
Undervalued by 68%.